|
⚲
|
| Keyboard |
| Thompson Craig B
✚
|
|
|---|---|
| CIK # | 0001423419 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001423419] | |
| 4 | [0001423419] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Charles River Laboratories International Inc | |
| Thompson Craig B | |
| Regeneron Pharmaceuticals Inc | |
| Merck & Co Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 1,962 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2026-01-02 | Grant | 155 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2025-05-21 | Grant | 946 | $134.98 | 127,691 |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2025-05-21 | Grant | 2,076 | $134.98 | 280,218 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 1,958 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2025-01-02 | Grant | 166 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2024-05-13 | Grant | 559 | $228.41 | 127,681 |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2024-05-13 | Grant | 1,311 | $228.41 | 299,446 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2024-01-02 | Grant | 1,607 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2024-01-02 | Grant | 135 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2023-05-15 | Grant | 664 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2023-05-15 | Grant | 1,669 | $192.36 | 321,049 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 477 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2023-01-03 | Grant | 40 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2023-01-03 | Grant | 244 | $0.00 | |
|
Charles River Laboratories International Inc CRL
Stock Options (Right to Buy) · derivative
|
2023-01-03 | Grant | 592 | $218.40 | 129,293 |
|
Regeneron Pharmaceuticals Inc REGN
Non-Qualified Stock Option (right to buy) · derivative
|
2022-10-03 | Grant | 3,216 | $0.00 | |
|
Regeneron Pharmaceuticals Inc REGN
Common Stock
|
2022-10-03 | Grant | 279 | $0.00 | |
|
Merck & Co Inc MRK
Phantom Stock · derivative
|
2018-05-25 | Grant | 3,130.82 | $59.09 | 185,000 |
|
Charles River Laboratories International Inc CRL
Common Stock
|
2018-05-14 | Grant | 653 | $0.00 | |
| showing 20 of 37 most recent transactions | |||||